Abstracts & Lectures
Sunday October 4, 2009: Opening lecture
Bacterial virulence factors as targets for new antibacterials. An overview
A_Blocker.pdf
(9752 Kb)
Monday October 5, 2009
Microbiota and intestinal immunity
1._N_Cerf-Bensussan.pdf
(5582 Kb)
Large-scale studies of the gut microbiota using an epidemiological approach
2._L_Engstrand.pdf
(3940 Kb)
The composition of the commensal microbiota: a metagenomic approach
3._J_Dore.pdf
(2866 Kb)
Finding the molecules that make probiotics work
4._P_Bron.pdf
(3000 Kb)
Oral abstract presentations
Multiplex PCR, PCR-RFLP and PFGE analysis for the molecular detection and characterization of diarrheagenic Escherichia coli strains
1._S_Bouzari.pdf
(479 Kb)
Prevalence of enterotoxins in E. coli clinical isolates causing urinary tract infection and bacteraemia
2._S_M__Soto.pdf
(425 Kb)
Characterization and location of the blaCTX-M-15 gene in enteroaggregative Escherichia coli causing
3._E_Guiral-Vilalta.pdf
(350 Kb)
Administration of capsule-selective endosialidase E minimises changes in organ gene expression induced by experimental systemic infection with Escherichia coli K1
4._P_Taylor.pdf
(485 Kb)
Efflux plays a key role in conferring high-level fluoroquinolone resistance in a Salmonella Typhimurium mutant decreasing to nearly susceptible levels in the presence of PAN
6._A_Fabrega.pdf
(90 Kb)
Overexpression of a marA homolog detected in a high-level fluoroquinolone resistant Yersinia enterocolitica mutant that shows an up-regulation of AcrA
7._A_Fabrega.pdf
(72 Kb)
Virulence blockers affect flagellar assembly and inhibit flagella-mediated virulence traits of Campylobacter jejuni
8._A_Veenendaal.pdf
(524 Kb)
A new MFS efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii "CraA"
11._P_Espinal.pdf
(437 Kb)
Tuesday October 6, 2009
Enteroaggregative E. coli: from the appetizer to dessert
Invasive enteropathogenic Escherichia coli
Campylobacter jejuni binding to fibronectin is essential for host colonization
3._M_E_Konkel.pdf
(1709 Kb)
Listeria crossing of the intestinal barrier and beyond
Inhibitors of quorum sensing
5._V_Sperandio.pdf
(1070 Kb)
Oral abstract presentations
Protein Interaction Networks of Human Pathogens
1._S_Blasche.pdf
(137 Kb)
AntiPathoGN: a FP7 project for the discovery of new drug targets in Gram-negative bacteria
3._X_Daura.pdf
(489 Kb)
The New Applications for Peptide-PNA Treated Bacteria in Immunology
6._A_Nikravesh.pdf
(246 Kb)
Antimicrobial effects of different aquatic and organic extracts of Cichorium intybus L against some gram positive and gram negative bacterial and Candida albicans
7.M_Hakemi.pdf
(623 Kb)
Statistical molecular design and consensus QSAR modelling of salicylidene acylhydrazides, type III secretion inhibitors in the gram-negative bacterium Yersinia
8._C_Lundvall.pdf
(253 Kb)
Wednesday October 7, 2009
Antibacterials as signalling agents
1._A_Dalhoff.pdf
(2016 Kb)
Type III secretion system inhibitors - Mechanism for virulence blockade in pathogenic Gram-negative bacteria
2._P_Keyser.pdf
(1788 Kb)
Efflux pump inhibitors to restore antibiotic efficacy
3__F_van_Bambeke.pdf
(3073 Kb)